Literature DB >> 32171713

Stabilizing Polysorbate 20 and 80 Against Oxidative Degradation.

Ariane Schmidt1, Atanas Koulov2, Jörg Huwyler3, Hanns-Christian Mahler1, Michael Jahn4.   

Abstract

Polysorbates are stabilizers typically required in therapeutic protein formulations. On account of their chemical structure, polysorbates are prone to degradation, which can render a pharmaceutical product instable or incompliant. The purpose of this study was to investigate if the addition of butylhydroxytoluene (BHT) and butylhydroxyanisole (BHA) protects polysorbate 20 (PS20) and polysorbate 80 (PS80) against oxidative degradation. PS20 and PS80 solutions containing BHA, BHT-or as control without an antioxidant-were stressed by exposure to air at 40°C for 7 weeks. The following assays were performed: ferrous oxidation-xylenol orange assay, liquid chromatography coupled to UV and mass spectrometry (MS), pH measurement, liquid chromatography fluorescence micelle assay, headspace-gas chromatography coupled with MS. PS20 and PS80 solutions containing an antioxidant were found to be more stable, as demonstrated by lower peroxide levels, lower free fatty acid contents, stable pH, intact polysorbate micelle structure/composition, and less volatile degradants. PS20 and PS80 solutions containing BHT or BHA are more stable against oxidative degradation compared to nonstabilized solutions. It might be beneficial to formulate bulk polysorbate with the antioxidant(s) to ensure stabilization during all process steps.
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antioxidants; chromatography; excipients; free radicals; mass spectrometry; oxidation; stability; surfactants

Mesh:

Substances:

Year:  2020        PMID: 32171713     DOI: 10.1016/j.xphs.2020.03.003

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation.

Authors:  Nidhi Doshi; Jamie Giddings; Lin Luis; Arthur Wu; Kyle Ritchie; Wenqiang Liu; Wayman Chan; Rosalynn Taing; Jeff Chu; Alavattam Sreedhara; Aadithya Kannan; Pervina Kei; Ian Shieh; Tobias Graf; Mark Hu
Journal:  Pharm Res       Date:  2021-03-12       Impact factor: 4.200

2.  Evaluating a Modified High Purity Polysorbate 20 Designed to Reduce the Risk of Free Fatty Acid Particle Formation.

Authors:  Nidhi Doshi; Kyle Ritchie; Tamanna Shobha; Jamie Giddings; Kathrin Gregoritza; Rosalynn Taing; Stephen Rumbelow; Jeff Chu; Anthony Tomlinson; Aadithya Kannan; Miguel Saggu; Si Kai Cai; Victor Nicoulin; Wenqiang Liu; Steve Russell; Lin Luis; Sandeep Yadav
Journal:  Pharm Res       Date:  2021-09-08       Impact factor: 4.200

3.  Development and Validation of Stability-Indicating HPLC Methods for the Estimation of Lomefloxacin and Balofloxacin Oxidation Process under ACVA, H2O2, or KMnO4 Treatment. Kinetic Evaluation and Identification of Degradation Products by Mass Spectrometry.

Authors:  Barbara Żuromska-Witek; Paweł Żmudzki; Marek Szlósarczyk; Anna Maślanka; Urszula Hubicka
Journal:  Molecules       Date:  2020-11-11       Impact factor: 4.411

4.  Nano Differential Scanning Fluorimetry-Based Thermal Stability Screening and Optimal Buffer Selection for Immunoglobulin G.

Authors:  Soo Hyun Kim; Han Ju Yoo; Eun Ji Park; Dong Hee Na
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-25

Review 5.  Photo-Oxidation of Therapeutic Protein Formulations: From Radical Formation to Analytical Techniques.

Authors:  Elena Hipper; Michaela Blech; Dariush Hinderberger; Patrick Garidel; Wolfgang Kaiser
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.